According to DelveInsight, the market of Diabetic Peripheral Neuropathy in 7MM was found to be approximately USD 2,275.52 Million in 2017. Among 7MM, the #UnitedStates had the highest #prevalent population of Diabetic Peripheral Neuropathy with about 12,522,483 cases in 2017. Among #EU5 countries, #Germany had the highest prevalent cases with 3,904,730 cases, followed by #Italy. However, #Spain registered the least number of #diagnosed prevalent cases. All these cases are expected to increase by 2030. Some of the key players in Diabetic Peripheral Neuropathy #Market includes Helixmith, Aptinyx Inc., WinSanTor, Regenacy Pharmaceuticals LLC, Novaremed AG, #GrünenthalGmbH, Glenmark Pharmaceuticals, and others. For more information visit: https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market #PeripheralNeuropathy #healthcare #biotechnology #pharmaceutical #lifescience #medical #marketresearch #market #consulting #neuropathy #diabetes